Zydus Lifesciences (ZYDUSLIFE) Corporate presentation summary

Strategic vision and mission

• Aims to transform lives globally through innovative life-sciences discoveries and healthcare solutions, empowering people to live healthier, more fulfilled lives.

Business scale and market leadership

• Achieved over $3 billion in FY26 revenue and $959 million EBITDA, with a market cap of $11.7 billion.

• Holds leadership positions in oncology, US generics, and consumer wellness brands in India.

• Operates 44 manufacturing facilities and 10 R&D centers globally, employing over 30,000 people.

Diversified portfolio and innovation

• Strong presence in pharma, consumer wellness, and MedTech, with differentiated products and high margins.

• Innovation pipeline includes NCEs, specialty drugs, biosimilars, and vaccines, with significant launches and regulatory milestones.

• Expanding global reach through acquisitions, partnerships, and digital platforms.